The precision medicine research spinout from Cold Spring Habor Laboratory has secured seed capital in a round led by Dynamk Capital. Envisagenics, a US-based precision medicine research spinout from Cold Spring Harbor Laboratory, secured $2.25m in a seed round today led by VC fund Dynamk Capital. Dynamk committed $500,000 to the round, investing alongside a group of unnamed private investors. Founded in 2014, Envisagenics has developed a drug discovery platform that aims to provide researchers with… This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
A US medical research start - up that uses artificial intelligence ( AI ) to detect diseases has secured $ 500 m of funding . Envisagenics is a spin - off from the non - profit private research firm the Cold Spring Harbor Laboratory in New York state , which specializes in molecular biology , neuroscience and genetics . it was formed in 2014 and has developed a system that uses machine learning to detect and analyse genetic deformities called splicing errors that can detect diseases . The investment round was led by venture capital firm Dynamk Capital , and comes after an undisclosed investment received in April from the Thiel foundation .